相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dendritic cells and cancer immunotherapy
Kristen J. Radford et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised proof-of-principle phase II study
Francesco de Rosa et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Epidemiology, Risk Factors, Prevention, and Early Detection of Melanoma
Said C. Azoury et al.
SURGICAL CLINICS OF NORTH AMERICA (2014)
Abnormal Development of Peripheral Lymphoid Organs in Mice Deficient in Lymphotoxin
Pietro De Togni et al.
JOURNAL OF IMMUNOLOGY (2014)
Historical review of melanoma treatment and outcomes
Carrie Lee et al.
CLINICS IN DERMATOLOGY (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study
Freddie Bray et al.
LANCET ONCOLOGY (2012)
Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used
W. Joost Lesterhuis et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
HLA-B35 correlates with a favorable outcome following adjuvant administration of an HLA-matched allogeneic melanoma vaccine
M. Lotem et al.
TISSUE ANTIGENS (2011)
Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model
Kimberley A. Stannard et al.
CANCER LETTERS (2010)
Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial
Redas Trepiakas et al.
CYTOTHERAPY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Vaccination with an Allogeneic Whole-Cell Melanoma Vaccine
Mark B. Faries et al.
CLINICAL CANCER RESEARCH (2009)
Immunotherapy for Advanced Melanoma
Lei Fang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Dendritic cell immunotherapy for stage IV melanoma
Michael G. E. O'Rourke et al.
MELANOMA RESEARCH (2007)
An update on malignant melanoma vaccine research - Insights into mechanisms for improving the design and potency of melanoma therapeutic vaccines
Stephen John Ralph
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2007)
Allogeneic and autologous melanoma vaccines:: Where have we been and where are we going?
VK Sondak et al.
CLINICAL CANCER RESEARCH (2006)
Dendritic-cell-based therapeutic vaccination against cancer
FO Nestle et al.
CURRENT OPINION IN IMMUNOLOGY (2005)
Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine
EC Hsueh et al.
SEMINARS IN CANCER BIOLOGY (2003)
Enhancing CTL responses to melanoma cell vaccines in vivo:: synergistic increases obtained using IFNγ primed and IFNβ treated B7-1+B16-F10 melanoma cells
S Dezfouli et al.
IMMUNOLOGY AND CELL BIOLOGY (2003)
Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma
R Soiffer et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB
MV Maus et al.
NATURE BIOTECHNOLOGY (2002)
Origin and differentiation of dendritic cells
C Ardavín et al.
TRENDS IN IMMUNOLOGY (2001)
Tumour rejection by gene transfer of 4-1BB ligand into a CD80+ murine squamous cell carcinoma and the requirements of co-stimulatory molecules on tumour and host cells
S Mogi et al.
IMMUNOLOGY (2000)
分享论文
